• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 020625 Product 001 in the OB_Disc list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N020625 001 5578610 Nov 26, 2013 U - 192
N020625 001 5578610*PED May 26, 2014
N020625 001 5738872 Feb 28, 2015
N020625 001 5738872*PED Aug 28, 2015
N020625 001 5855912 Feb 28, 2015
N020625 001 5855912*PED Aug 28, 2015
N020625 001 5932247 Feb 28, 2015
N020625 001 5932247*PED Aug 28, 2015
N020625 001 6037353 Mar 14, 2017 U - 138
N020625 001 6037353*PED Sep 14, 2017
N020625 001 6113942 Feb 28, 2015
N020625 001 6113942*PED Aug 28, 2015
N020625 001 7135571 May 18, 2014 Y
N020625 001 7135571*PED Nov 18, 2014
N020625 001 7138524 May 18, 2014 Y
N020625 001 7138524*PED Nov 18, 2014

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through July 2014
Patent and Generic Drug Product Data Last Updated August 29, 2014

-
-